LiveWire Ergogenics (OTC: LVVV), a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry, has formed a dedicated research team to explore the efficacy of CBD for the treatment of specific ailments in high-performance horses. An article discussing the company reads, “The soon-to-commence research project will explore the potential application of CBD for high-performance horses in the hunter/jumper and dressage sectors. The research will target ‘the use, efficacy, safety and future of CBD’ for treating equine joint inflammation, anxiety, gastronomical disorders and pain as well as supporting general well-being (http://cnw.fm/4BOz3). Its motive is to ‘accelerate the advancement of the medical knowledge in the field, support the continuing effort for further legalization and eventually provide credible and high-quality applications that will benefit the entire equestrian field,’ the company’s news release states.”
To view the full article, visit http://cnw.fm/6i1dE
About LiveWire Ergogenics Inc.
LiveWire Ergogenics Inc. (LVVV) specializes in identifying and monetizing current and future trends in the human and veterinarian health and wellness industry. The company is focused on acquiring, managing and licensing specialized closed-loop turnkey, cannabis, real-estate locations of fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California and the statewide distribution of these products. This includes verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Verification System, and the development, licensing and distribution of legal, high-quality, cannabinoid-based products and services. LiveWire Ergogenics does not sell or distribute products that are in violation of the United States Controlled Substance Act. For more information, visit the company’s website at www.LiveWireErgogenics.com.
NOTE TO INVESTORS: The latest news and updates relating to LVVV are available in the company’s newsroom at http://cnw.fm/LVVV
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com